Table 3.
Characteristics | Number | Percentage (%) |
---|---|---|
Primary purpose | ||
Diagnosis | 3 | 42.86 |
Treatment | 1 | 14.29 |
Screening | 1 | 14.29 |
Health services research | 1 | 14.29 |
Other | 1 | 14.29 |
Intervention | ||
Behavioral | 3 | 42.86 |
Device | 1 | 14.29 |
Diagnostic test | 2 | 28.57 |
Other | 1 | 14.29 |
Intervention model | ||
Parallel assignment | 5 | 71.43 |
Single group assignment | 2 | 28.57 |
Sequential assignment | 0 | 0 |
Crossover assignment | 0 | 0 |
Factorial assignment | 0 | 0 |
Allocation | ||
Randomized | 4 | 57.14 |
Nonrandomized | 1 | 14.29 |
N/A | 2 | 28.57 |
Masking | ||
Single | 2 | 28.57 |
Double | 1 | 14.29 |
None (open-label) | 4 | 57.14 |
Registered year | ||
2004-2010 | 0 | 0 |
2011-2016 | 1 | 14.29 |
2017-2021 | 6 | 85.71 |
Enrollment | ||
0-99 | 1 | 14.29 |
100-500 | 6 | 85.71 |
>500 | 0 | 0 |
Gender | ||
Female only | 1 | 14.29 |
Both | 6 | 85.71 |
Age | ||
<18 | 0 | 0 |
≥18 | 7 | 100.00 |
All | 0 | 0 |
Status | ||
Not recruiting | 1 | 14.29 |
Recruiting | 3 | 42.86 |
Completed | 3 | 42.86 |
Study results | ||
Has results | 1 | 14.29 |
No results available | 6 | 85.71 |
Sponsor | ||
University | 4 | 57.14 |
Hospital | 2 | 28.57 |
Company/industry | 1 | 14.29 |
Institute | 0 | 0 |
Other | 0 | 0 |
Collaborators | ||
University | 1 | 14.29 |
Hospital | 3 | 42.86 |
Company/industry | 1 | 14.29 |
Institute | 2 | 28.57 |
Other | 0 | 0 |
Location | ||
America | 3 | 42.86 |
Europe | 1 | 14.29 |
Asia | 3 | 42.86 |